Business Wire

Riskified Partners with Outpayce from Amadeus to Enable and Secure Payments for Airlines and Travel Merchants Worldwide

7.4.2026 14:00:00 CEST | Business Wire | Press Release

Share

Riskified, a leader in ecommerce fraud and risk intelligence, today announced a partnership with Outpayce from Amadeus. This partnership boosts Outpayce’s trusted travel payment platform with Riskified’s AI-powered fraud prevention suite and Chargeback Guarantee model, creating a game-changing solution for airlines worldwide. The landscape of airline payments is evolving, and we're proud to share a major milestone that will reshape the way airlines approach fraud management.

Outpayce from Amadeus is a global travel payments orchestrator and specialized fintech enabler, empowering airlines and travel merchants to streamline complex payment processes, optimize costs, and enhance customer experiences. Purpose-built for the travel industry, Outpayce delivers innovation, flexibility, and seamless integration within the Amadeus ecosystem, supporting secure, efficient, and scalable payment operations across the entire traveler journey.

With Riskified integrating into Outpayce’s ecosystem, carriers all over the world can benefit from AI-decisioning and a risk management solution that creates revenue predictability through guaranteed defined approval rates, while significantly reducing complexity and the cost of fraud. With this new partnership, Riskified becomes the first chargeback guarantee solution in Outpayce’s ecosystem, elevating its value to airlines across the globe.

“Our innovation-first collaboration with Riskified is a major step forward in helping airlines combat fraud more effectively,” said Vasken Tokatlian, VP Partnerships at Outpayce from Amadeus. “By integrating Riskified into Outpayce’s ecosystem we are expanding the choice available to airlines worldwide—equipping them with additional tools to reduce fraud losses, lower operational costs, and seamless, secure payment experiences.”

“By partnering with Outpayce from Amadeus, we are giving airlines the confidence to grow their business, secure in the knowledge that every transaction is protected from fraud,” said Max Meister Admoni, Global Head of Partnerships at Riskified.

A major Asia-Pacific international airline will be the first merchant to go live with the integration in 2026. This launch paves the way for successful implementation with other merchants looking to enhance the traveler experience with advanced AI capabilities.

This partnership delivers value to airlines executing on growth strategies and with variable risk profiles. For carriers in high-risk areas, where chargeback volumes often create significant financial and administrative challenges, Riskified’s technology offers a way to reduce fraud losses, streamline operations, and expand confidently into new territories. Meanwhile, every airline stands to benefit from the highest accuracy in fraud detection, an intelligent, adaptive checkout flow that maximizes bookings, a reduction in manual reviews, and peace of mind that comes with Riskified’s Chargeback Guarantee protection.

High ticket values, frequent card-not-present transactions, and the attractiveness of travel bookings to fraudsters create a perfect storm for elevated fraud and chargeback rates. And fraudsters continue to find creative and sophisticated ways to exploit gaps in airline policies and processes. One Riskified analysis found that flight bookings over the past year were +14% riskier than the previous year.

This is where the collaboration between Riskified and Outpayce provides a much-needed solution for the industry. Together, they offer a sophisticated, technology-driven approach to tackling fraud and chargebacks, addressing these challenges head-on.

  • Advanced fraud prevention: Using state-of-the-art machine learning and AI technology, Riskified delivers precise fraud detection with faster, more accurate decision-making that surpasses traditional, rules-based systems.
  • Guaranteed chargeback protection: Riskified provides Chargeback Guarantee services, eliminating the financial risk for airlines as stated in What is a chargeback guarantee? - Riskified.
  • Sector expertise: Together, Outpayce and Riskified’s global merchant network offer a strong concentration of travel-related transactions from airlines, OTAs, transportation providers, tour and event operators, and more, giving unprecedented intelligence into the identities of travelers purchasing flights and fraud detection accuracy.
  • Improved operational efficiency: By automating fraud detection and reducing reliance on manual reviews, Riskified helps airlines focus on higher-value tasks while saving valuable time and resources.

At a time where booking patterns and payment preferences are frequently changing, Riskified and Outpayce enable businesses to stay agile while keeping fraud under control. Interested in joining the growing list of airlines transforming their fraud prevention approach? Speak with one of our experts at Riskified or Outpayce from Amadeus.

About Riskified
Riskified (NYSE:RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world’s biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists, and researchers, Riskified’s AI-powered fraud and risk intelligence platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Learn more at riskified.com.

About Amadeus
Amadeus makes the experience of travel better for everyone, everywhere by inspiring innovation, partnerships and responsibility to people, places and planet. Our technology powers the travel and tourism industry. Inspiring more open ways of working. More connected ways of thinking, centered around the traveler. Our open platform connects the global travel and hospitality ecosystem. From startups to big industry players and governments too. Together, transforming how travel works. We are working to make travel a force for social and environmental good. A collective responsibility to protect and improve the people and places we visit, ensuring travel continues to make positive contribution to our world. We apply innovation to meet new needs, to solve real challenges. Our truly diverse global workforce, made up of 150 nationalities, is passionate about travel and technology. We are an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. We have also been recognized by the Dow Jones Sustainability Index for the last 13 years. Amadeus. It's how travel works better.

Learn more about Amadeus at www.amadeus.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260331782202/en/

Contacts

Corporate Communications:
Cristina Dinozo
Senior Director of Communications
press@riskified.com

Investor Relations:
ir@riskified.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press Release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press Release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press Release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 14:00:00 CEST | Press Release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press Release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye